Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIStorm is a semiconductor company that develops high-performance, ultra-low-power AI processors designed for "AI-in-Sensor" applications. The company utilizes a proprietary Charge Domain Processing (CDP) architecture that allows AI to process data directly from sensors in the analog domain, significantly reducing latency and power consumption compared to traditional digital solutions. In the healthcare and life sciences sectors, AIStorm’s technology enables advanced real-time monitoring in wearable devices, such as continuous glucose monitors and cardiac sensors. Their platform also supports high-resolution medical imaging and edge-based diagnostic tools by providing efficient processing of complex physiological signals. By moving AI processing to the sensor edge, AIStorm facilitates the development of more responsive, battery-efficient, and privacy-conscious medical hardware. This technology is particularly disruptive for the Internet of Medical Things (IoMT) where power constraints often limit device capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIStorm.